Need for a trial of solanezumab in mild Alzheimer's disease.
York Trials Unit, University of York, York, UK david.torgerson@york.ac.uk.
David
D
Torgerson
D000544:Alzheimer Disease / Q000188:drug therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D006801:Humans; D008402:Mass Media
D061067:Antibodies, Monoclonal, Humanized